Brett Ley1, Dara G Torgerson2, Justin M Oldham3, Ayodeji Adegunsoye4, Shuo Liu5, Jie Li6, Brett M Elicker7, Travis S Henry7, Jeffrey A Golden1, Kirk D Jones8, Amy Dressen9, Brian L Yaspan9, Joseph R Arron9, Imre Noth10, Thomas J Hoffmann11, Paul J Wolters1. 1. Department of Medicine. 2. Department of Human Genetics, McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada. 3. Department of Medicine, University of California Davis, Davis, California. 4. Department of Medicine, University of Chicago, Chicago, Illinois. 5. Department of Respiratory Medicine, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China. 6. University of California Davis Bioinformatics Core, Davis, California. 7. Department of Radiology and Biomedical Imaging. 8. Department of Pathology, and. 9. Genentech, South San Francisco, California; and. 10. Department of Medicine, University of Virginia, Charlottesville, Virginia. 11. Department of Epidemiology and Biostatistics, Institute for Human Genetics, University of California San Francisco, San Francisco, California.
Abstract
Rationale: Rare genetic variants in telomere-related genes have been identified in familial, idiopathic, and rheumatoid arthritis-associated pulmonary fibrosis. Short peripheral blood leukocyte (PBL) telomere length predicts poor outcomes in chronic hypersensitivity pneumonitis (CHP). Objectives: Determine the prevalence and clinical relevance of rare protein-altering variants in telomere-related genes in patients with CHP. Methods: Next-generation sequences from two CHP cohorts were analyzed to identify variants in TERT (telomerase reverse transcriptase), TERC (telomerase RNA component), DKC1 (dyskerin pseudouridine synthase 1), RTEL1 (regulator of telomere elongation helicase 1), PARN (poly[A]-specific RNase), and TINF2 (TERF1-interacting nuclear factor 2). To qualify, variants were required to have a minor allele frequency less than 0.005 and be predicted to be damaging to protein function. Variant status (binary variable) was used in statistical association tests, including Cox proportional hazard models for transplant-free survival. PBL telomere length was measured using quantitative PCR.Measurements and Main Results: Qualifying variants were identified in 16 of 144 patients (11.1%; 95% confidence interval [CI], 6.5-17.4) in the discovery cohort and 17 of 209 patients (8.1%; 95% CI, 4.8-12.7) in the replication cohort. Age- and ancestry-adjusted PBL telomere length was significantly shorter in the presence of a variant in both cohorts (discovery: -561 bp; 95% CI, -933 to -190; P = 0.003; replication: -612 bp; 95% CI, -870 to -354; P = 5.30 × 10-6). Variant status was significantly associated with transplant-free survival in both cohorts (discovery: age-, sex-, and ancestry-adjusted hazard ratio, 3.73; 95% CI, 1.92-7.28; P = 0.0001; replication: hazard ratio, 2.72; 95% CI, 1.26-5.88; P = 0.011).Conclusions: A substantial proportion of patients diagnosed with CHP have rare, protein-altering variants in telomere-related genes, which are associated with short peripheral blood telomere length and significantly reduced transplant-free survival.
Rationale: Rare genetic variants in telomere-related genes have been identified in familial, idiopathic, and rheumatoid arthritis-associated pulmonary fibrosis. Short peripheral blood leukocyte (PBL) telomere length predicts poor outcomes in chronic hypersensitivitypneumonitis (CHP). Objectives: Determine the prevalence and clinical relevance of rare protein-altering variants in telomere-related genes in patients with CHP. Methods: Next-generation sequences from two CHP cohorts were analyzed to identify variants in TERT (telomerase reverse transcriptase), TERC (telomerase RNA component), DKC1 (dyskerin pseudouridine synthase 1), RTEL1 (regulator of telomere elongation helicase 1), PARN (poly[A]-specific RNase), and TINF2 (TERF1-interacting nuclear factor 2). To qualify, variants were required to have a minor allele frequency less than 0.005 and be predicted to be damaging to protein function. Variant status (binary variable) was used in statistical association tests, including Cox proportional hazard models for transplant-free survival. PBL telomere length was measured using quantitative PCR.Measurements and Main Results: Qualifying variants were identified in 16 of 144 patients (11.1%; 95% confidence interval [CI], 6.5-17.4) in the discovery cohort and 17 of 209 patients (8.1%; 95% CI, 4.8-12.7) in the replication cohort. Age- and ancestry-adjusted PBL telomere length was significantly shorter in the presence of a variant in both cohorts (discovery: -561 bp; 95% CI, -933 to -190; P = 0.003; replication: -612 bp; 95% CI, -870 to -354; P = 5.30 × 10-6). Variant status was significantly associated with transplant-free survival in both cohorts (discovery: age-, sex-, and ancestry-adjusted hazard ratio, 3.73; 95% CI, 1.92-7.28; P = 0.0001; replication: hazard ratio, 2.72; 95% CI, 1.26-5.88; P = 0.011).Conclusions: A substantial proportion of patients diagnosed with CHP have rare, protein-altering variants in telomere-related genes, which are associated with short peripheral blood telomere length and significantly reduced transplant-free survival.
Authors: Hilary E Faust; Jeffrey A Golden; Raja Rajalingam; Angelia S Wang; Gary Green; Steven R Hays; Jasleen Kukreja; Jonathan P Singer; Paul J Wolters; John R Greenland Journal: Thorax Date: 2017-04-26 Impact factor: 9.139
Authors: Jonathan K Alder; Susan E Stanley; Christa L Wagner; Makenzie Hamilton; Vidya Sagar Hanumanthu; Mary Armanios Journal: Chest Date: 2015-05 Impact factor: 9.410
Authors: Chad A Newton; Kiran Batra; Jose Torrealba; Julia Kozlitina; Craig S Glazer; Carlos Aravena; Keith Meyer; Ganesh Raghu; Harold R Collard; Christine Kim Garcia Journal: Eur Respir J Date: 2016-08-18 Impact factor: 16.671
Authors: Joshua J Mooney; Brett M Elicker; Thomas H Urbania; Misha R Agarwal; Christopher J Ryerson; Michelle Linh T Nguyen; Prescott G Woodruff; Kirk D Jones; Harold R Collard; Talmadge E King; Laura L Koth Journal: Chest Date: 2013-08 Impact factor: 9.410
Authors: Bridget D Stuart; Jungmin Choi; Samir Zaidi; Chao Xing; Brody Holohan; Rui Chen; Mihwa Choi; Pooja Dharwadkar; Fernando Torres; Carlos E Girod; Jonathan Weissler; John Fitzgerald; Corey Kershaw; Julia Klesney-Tait; Yolanda Mageto; Jerry W Shay; Weizhen Ji; Kaya Bilguvar; Shrikant Mane; Richard P Lifton; Christine Kim Garcia Journal: Nat Genet Date: 2015-04-13 Impact factor: 41.307
Authors: Brett Ley; Chad A Newton; Isabel Arnould; Brett M Elicker; Travis S Henry; Eric Vittinghoff; Jeffrey A Golden; Kirk D Jones; Kiran Batra; Jose Torrealba; Christine Kim Garcia; Paul J Wolters Journal: Lancet Respir Med Date: 2017-06-22 Impact factor: 30.700
Authors: Steven J Van Dyken; Hong-Erh Liang; Ram P Naikawadi; Prescott G Woodruff; Paul J Wolters; David J Erle; Richard M Locksley Journal: Cell Date: 2017-04-20 Impact factor: 41.582
Authors: Haruhiko Furusawa; Jonathan H Cardwell; Tsukasa Okamoto; Avram D Walts; Iain R Konigsberg; Jonathan S Kurche; Tami J Bang; Marvin I Schwarz; Kevin K Brown; Jonathan A Kropski; Mauricio Rojas; Carlyne D Cool; Joyce S Lee; Paul J Wolters; Ivana V Yang; David A Schwartz Journal: Am J Respir Crit Care Med Date: 2020-11-15 Impact factor: 21.405
Authors: Sydney B Montesi; Jolene H Fisher; Fernando J Martinez; Moisés Selman; Annie Pardo; Kerri A Johannson Journal: Am J Respir Crit Care Med Date: 2020-08-15 Impact factor: 21.405
Authors: Claire C Cutting; Willis S Bowman; Nam Dao; Janelle Vu Pugashetti; Christine Kim Garcia; Justin M Oldham; Chad A Newton Journal: Chest Date: 2021-01-21 Impact factor: 9.410
Authors: Ayodeji Adegunsoye; Julie Morisset; Chad A Newton; Justin M Oldham; Eric Vittinghoff; Angela L Linderholm; Mary E Strek; Imre Noth; Christine Kim Garcia; Paul J Wolters; Brett Ley Journal: Eur Respir J Date: 2021-03-04 Impact factor: 16.671
Authors: Aernoud A van Batenburg; Karin M Kazemier; Matthijs F M van Oosterhout; Joanne J van der Vis; Jan C Grutters; Roel Goldschmeding; Coline H M van Moorsel Journal: ERJ Open Res Date: 2021-05-31
Authors: Evans R Fernández Pérez; James L Crooks; Jeffrey J Swigris; Joshua J Solomon; Michael P Mohning; Tristan J Huie; Matthew Koslow; David A Lynch; Steve D Groshong; Kaitlin Fier Journal: ERJ Open Res Date: 2021-06-07
Authors: Shuo Liu; Melody P Chung; Brett Ley; Sarah French; Brett M Elicker; David F Fiorentino; Lorinda S Chung; Francesco Boin; Paul J Wolters Journal: Thorax Date: 2021-07-16 Impact factor: 9.102